Adial Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $22.55 million, with shareholders equity totaling $-38.38 million.
The company employs approximately 6 people and operates in the Health sector, within the Pharmaceutical Products industry.
Over the past 12 months, Adial Pharmaceuticals Inc. reported $- in revenue, generating net income of $-57.80 million.
Key financial metrics include a P/E ratio of -0.39, a price-to-book (P/B) ratio of -0.59, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker ADIL.